Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency

Clinical trial NCT00056589 · COMPLETED

Trial details

NCT number: NCT00056589
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Congenital FXIII Deficiency

Start date: 2003-03-01
Primary completion: 2003-10-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.